The guidance, in the form of a question-and-answer document, relates to particularities of monoclonal antibodies for veterinary use, such as quality control for potential contaminants, stability testing, reproductive safety studies and data to address potential for indirect adverse effects.

Keywords: veterinary, monoclonal antibody

Current effective version

Document history

Share this page